Received Jun 2, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
has a patient that apparently had the first dose 5 years ago; This non-serious case was reported by a physician via sales rep and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (apparently had the first dose 5 years ago). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: has a patient that apparently had the first dose 5 years ago). The outcome of the incomplete course of vaccination was not reported. Additional Information: GSK receipt date: 29-MAY-2025 A physician wants to know the efficacy of Shingrix if the patient waits over a year for their second dose. She also wants to know when it's recommend it to repeat the two doses. She mentioned that she had a patient that apparently had the first dose 5 years ago. She wants to know if she could give this patient the two doses so the patient could have the over the 90 percent efficacy. No further information was provided. Till the time of reporting, the patient did not receive second dose of Shingrix, which led to incomplete course of vaccination. .